ng-nitroarginine methyl ester has been researched along with Cutaneous Fistula in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anic, T; Barisic, I; Berkopic, L; Blagaic, AB; Brcic, I; Brcic, L; Coric, M; Drmic, D; Ilic, S; Ivica, M; Klicek, R; Kocman, I; Radic, B; Rokotov, DS; Seiwerth, S; Sever, M; Sikiric, P; Vrcic, H; Vuksic, T; Zoricic, I | 1 |
| Becejac, T; Brcic, L; Cesarec, V; Djakovic, Z; Drmic, D; Misic, M; Olujic, D; Rokotov, DS; Seiwerth, S; Sikiric, P | 1 |
2 other study(ies) available for ng-nitroarginine methyl ester and Cutaneous Fistula
| Article | Year |
|---|---|
Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats: role of the nitric oxide-system.
Topics: Anesthesia; Animals; Anti-Ulcer Agents; Arginine; Colonic Diseases; Cutaneous Fistula; Enzyme Inhibitors; Inflammatory Bowel Diseases; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Peptide Fragments; Proteins; Rats; Rats, Wistar | 2008 |
Pentadecapeptide BPC 157 and the esophagocutaneous fistula healing therapy.
Topics: Animals; Arginine; Cutaneous Fistula; Drug Interactions; Esophageal Diseases; Male; NG-Nitroarginine Methyl Ester; Peptide Fragments; Proteins; Rats; Rats, Wistar; Wound Healing | 2013 |